2'-deoxy-3',5'-di-o-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine has been researched along with Cancer of Intestines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, K; Nagatomi, H; Takeshita, S | 1 |
1 other study(ies) available for 2'-deoxy-3',5'-di-o-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine and Cancer of Intestines
Article | Year |
---|---|
Alleviation of intestinal lesions by combined treatment with a 5-fluoro-2'-deoxyuridine (FUDR) derivative and alpha-difluoromethylornithine (DFMO)[correction of DMFO] in tumor-bearing mice.
Topics: Amine Oxidase (Copper-Containing); Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Eflornithine; Erythrocyte Count; Floxuridine; Intestinal Neoplasms; Male; Mice; Mice, Inbred ICR; Sarcoma, Experimental | 1992 |